siRNA treatment decreases triglycerides in people along with unusual problem

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran decreased triglyceride degrees through 80% and lowered the risk of pancreatitis in individuals along with persistent chylomicronemia, with or without a genetic diagnosis.